title: A delicate balance: the cost effectiveness of new antiplatelet agents.
authors: Departments of Medicine and Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California. Electronic address: kazi@ucsf.edu.
authors: Dhruv S
authors: DS
authors: Kazi
authors: Departments of Health Research and Policy and Medicine, Stanford University School of Medicine, Stanford, California.
authors: Mark A
authors: MA
authors: Hlatky
mesh_terms: D054058:Acute Coronary Syndrome / Q000191:economics* / Q000401:mortality*; D000241:Adenosine / Q000031:analogs & derivatives* / Q000191:economics; D000077144:Clopidogrel; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000191:economics*; D000077486:Ticagrelor; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000191:economics
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine
keywords: antiplatelet therapies; cost effectiveness; economic evaluation; ticagrelor